Clinical Study
Relation of Asymmetric Dimethylarginine Levels to Macrovascular Disease and Inflammation Markers in Type 2 Diabetic Patients
Table 2
Comparison of the common parameters in all diabetic patients and the control group.
| | | DM | Control | values Significance |
| | Age (years) | 59.41 ± 8.81 | 55.00 ± 7.34 | <0.05 | | Creatinine (mg/dL) | 0.93 ± 0.23 | 0.82 ± 0.16 | <0.05 | | Triglyceride (mg/dL) | 187.65 ± 105.15 | 140.78 ± 77.49 | <0.01 | | T. cholesterol (mg/dL) | 185.78 ± 45.18 | 201.03 ± 35.95 | <0.05 | | HDL (mg/dL) | 50.36 ± 12.24 | 53.79 ± 13.17 | >0.05 | | LDL (mg/dL) | 117.91 ± 35.51 | 135.50 ± 34.13 | <0.01 | Sedimentation (mm/hr)
| 21.96 ± 19.21 | 12.87 ± 8.42 | <0.01 | | hsCRP (mg/L) | 7.21 ± 10.37 | 2.29 ± 1.86 | <0.01 | | Fibrinogen (mg/dL) | 377.86 ± 81.06 | 347.50 ± 57.32 | <0.01 | | Homocysteine (umol/L) | 11.58 ± 3.86 | 10.61 ± 3.53 | >0.05 | | Car.Int-R. (mm) | 0.92 ± 0.22 | 0.80 ± 0.22 | <0.01 | | Car.Int-L (mm) | 0.93 ± 0.23 | 0.80 ± 0.20 | <0.01 | | ADMA (umol/L) | 0.45 ± 0.21 | 0.32 ± 0.13 | <0.001 |
|
|
